“Novel antimicrobial peptides and oligomers to combat Antimicrobial Resistance (AMR)”
Peptomer Therapeutics is proudly headquartered within the BSC BioNEST bio-incubator, Regional Center for Biotechnology, Faridabad. Our dedicated team comprises accomplished organic chemists and molecular biologists who share a common goal: pioneering innovative alternatives to antibiotics as a formidable solution to combat Antimicrobial Resistance (AMR).
Novel oligomers effective against Multi-Drug Resistant (MDR) bacteria
New generation peptidomimetics with broad-spectrum antimicrobial activity
New compounds effective against a variety of bacteria and fungi
Peptomer Therapeutics has successfully secured startup funding from NIDHI-PRAYAS, a program under the Ministry of Science and Technology.
Peptomer Therapeutics has marked a significant achievement by securing a prestigious BIG grant from the Biotechnology Industry Research Assistance Council (BIRAC).
We have secured a startup grant from the Ministry of Agriculture, to develop novel drug delivery solutions to fight AMR in daiary animals.
Peptomer has secured a seed fund of ₹ 15 million from founders. To develop new gerantion oligomers and peptidomimetics as alteranties to antbitoics.
“Our Novel Oligomers, Peptides, and Oligomer-Peptides Hold the Potential to Enhance the Potency of Existing Ineffective Antibiotics.”
Peptomer Therapeutics Private Limited
Lab-7, BSC BioNEST Bio-Incubator, 3rd milestone,
Faridabad – Gurgaon Rd, expressway, Faridabad, Haryana 121001